Updated 28/08/2026
Photo: Laparoscopic operating theatre, by Dr.jayesh amin (Wikimedia), cropped for layout · Licensed CC BY-SA 3.0 · Source
Plain-language summary of research published in the Georgian Medical Journal. Written for the general public by the GMJ News editorial team.
Bariatric surgery is well established for severe obesity and type 2 diabetes — but its role in type 1 diabetes remains far less defined, backed only by small, heterogeneous case series. A case report in the Georgian Medical Journal adds a detailed data point: a 33-year-old woman with 19 years of type 1 diabetes and morbid obesity who underwent laparoscopic sleeve gastrectomy.
Why This Combination Is Rare
The prevalence of overweight and obesity in people with type 1 diabetes is rising, and it compounds the disease: it contributes to insulin resistance, higher insulin requirements, and elevated cardiovascular risk. Bariatric surgery’s evidence base, though, was built almost entirely on type 2 diabetes and obesity without type 1 diabetes in the mix — leaving clinicians with limited guidance when a type 1 patient’s obesity becomes severe enough to warrant surgical consideration.
The Patient and the Procedure
The patient, 33 years old with a 19-year history of type 1 diabetes and a body mass index of 40.8 kg/m² (morbid obesity), underwent laparoscopic sleeve gastrectomy after multidisciplinary evaluation. Preoperatively, her glycaemic control was suboptimal — HbA1c of 7.4% — with high insulin requirements, particularly for meal-time (prandial) dosing. She also carried hypertension, dyslipidaemia, and an active smoking history going into surgery.
At a glance — the headline figures.
At six months postoperatively, the results were substantial: BMI fell from 40.8 to 27.2 kg/m², and HbA1c improved from 7.4% to 5.8% — a meaningful shift into much better glycaemic control. Total daily insulin requirements decreased markedly as well. For a population that bariatric surgery’s evidence base has largely overlooked, this case adds a concrete, well-documented data point supporting the idea that sleeve gastrectomy can meaningfully help select type 1 diabetes patients with severe obesity — while still leaving the larger question of who exactly should qualify for wider clinical trials to answer.
Read the Original Research
Original article: Weight-Loss Surgery in Type 1 Diabetes: A Case That Challenges Old Boundaries
Published in: Georgian Medical Journal, Vol. 1 No. 1 (2026)
DOI: 10.5281/zenodo.19130904
📄 Read the full article at gmj.ge →
Georgian Medical Journal (GMJ) · ISSN 3088-4322 · gmj.ge · Open Access CC BY 4.0 · Published by the Public Health Institute of Georgia (PHIG). This summary is an independent editorial product of GMJ News; for clinical decisions, consult the original peer-reviewed article and a qualified professional.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
